Benzinga's Top Downgrades

Analysts at Piper Jaffray downgraded Vitamin Shoppe VSI from Overweight to Neutral. The target price for Vitamin Shoppe has been lowered from $45 to $44. Vitamin Shoppe's shares closed at $45.40 yesterday. Analysts at RBC Capital downgraded Athlon Energy ATHL from Outperform to Sector Perform. The target price for Athlon Energy has been raised from $55 to $59. Athlon Energy's shares closed at $58.32 yesterday. Analysts at Bank of America downgraded Seattle Genetics SGEN from Neutral to Underperform. The target price for Seattle Genetics has been lowered from $ $40 to $34. Seattle Genetics' shares closed at $38.39 yesterday. Analysts at Brean Capital downgraded Endocyte ECYT from Buy to Hold. Endocyte's shares closed at $6.99 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!